504345 — Oasis Nutraceuticals Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Oasis Nutraceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2014 March 31st  | 2015 March 31st  | 2016 March 31st  | 2017 March 31st  | 2018 March 31st  | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IAS | IAS | IAS | IAS | IAS | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 0 | 0 | 1.1 | 58.2 | 47.5 | 
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.001 | -1.65 | -2.5 | 
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.12 | 6.55 | 1.59 | 61.7 | 50.8 | 
| Operating Profit | -5.12 | -6.55 | -0.488 | -3.5 | -3.38 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.87 | 1.65 | 4.93 | 1.18 | 1 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.97 | -0.675 | 3.73 | 0.816 | 0.743 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.97 | -0.675 | 3.73 | 0.816 | 0.743 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 2.97 | -0.675 | 3.73 | 0.816 | 0.743 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.029 | -0.007 | 0.037 | 0.008 | 0.007 | 
| Dividends per Share |